Effect of 23-Valent Pneumococcal Polysaccharide Vaccine Inoculated During Anti-Cancer Treatment Period in Elderly Lung Cancer Patients on Community-Acquired Pneumonia Hospitalization: A Nationwide Population-Based Cohort Study

Effect of 23-Valent Pneumococcal Polysaccharide Vaccine Inoculated During Anti-Cancer Treatment Period in Elderly Lung Cancer Patients on Community-Acquired Pneumonia Hospitalization: A Nationwide Population-Based Cohort Study

To evaluate effectiveness of 23-valent pneumococcal polysaccharide vaccine (PPSV23) inoculated during defined “vaccination period,” first 6 months post cancer diagnosis (ie, an anti-cancer treatment period), in elderly lung cancer patients on community-acquired pneumonia (CAP) hospitalization incide...

Full description

Bibliographic Details
Main Authors: Chiou, Wen-Yen, Hung, Shih-Kai, Lai, Chun-Liang, Lin, Hon-Yi, Su, Yu-Chieh, Chen, Yi-Chun, Shen, Bing-Jie, Chen, Liang-Cheng, Tsai, Shiang-Jiun, Lee, Moon-Sing, Li, Chung-Yi
Format: Online
Language:English
Published: Wolters Kluwer Health 2015
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4504648/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4504648/

Similar Items